Innovation Pharmaceuticals Inc (IPIX)

[Patientspeople]

The author of the top COVID-19 potentials listed according to stage of clinical development. Brilacidan is in the TOP 10 of all known candidates world wide. The author, Michael Cembalest is the Chairman of Market and Investment Strategy for J.P. Morgan Asset Management. He is responsible for leading the strategic market and investment insights across the firm's Institutional, Funds, and Private Banking businesses.

Brilacidin has already completed Phase II in human trials and is currently moving along in the Regional Biocontainment Lab Testing. The chart was updated as of April 23rd.

Why the price hasn't taken off, many factors?? Will it take off if it keeps preforming in testing?? I don't see why it wouldn't, still a long shot if you look at the stock price but being listed among the top 10 potential candidates, HUGE and on the radar!!! The demand and federal funding is still sky high for a cure or fix.